Freestone Capital Holdings’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,100
Closed -$43.3M 404
2018
Q2
$43.3M Buy
+1,100
New +$57.4K 0.27% 4
2018
Q1
Sell
-1,111
Closed -$52.2K 347
2017
Q4
$496K Buy
+1,111
New +$38.9K 0.03% 267

Other funds holding GMED

Freestone Capital Holdings's GMED Position: Q3 2018 in Review

Freestone Capital Holdings sold out of Globus Medical (GMED) in Q3 2018, closing a stake of 1,100 shares — an estimated $43.3M sold.

Freestone Capital Holdings first reported a position in GMED in Q4 2017 and held it in 2 quarters. The position peaked at $43.3M in Q2 2018. 312 funds tracked by Wall St. Rank hold GMED as of Q3 2018.

  • Freestone Capital Holdings reported no remaining Globus Medical position as of Q3 2018 after selling out during the quarter.
  • Freestone Capital Holdings sold 1,100 Globus Medical shares in Q3 2018, an estimated $43.3M.
  • Freestone Capital Holdings first reported a position in Globus Medical in Q4 2017 and held it in 2 quarters.
  • Freestone Capital Holdings's Globus Medical position peaked at $43.3M in Q2 2018.
  • 312 funds tracked by Wall St. Rank held Globus Medical as of Q3 2018.

Based on Freestone Capital Holdings's 13F filing for Q3 2018, filed 13 Nov 2018.